We also proposed to revise 427.302(d)(1)(ii) by removing If neither a published payment limit nor manufacturer-reported ASP or WAC data are available, CMS will use WAC data from other public sources to calculate 106 percent of WAC, which, solely for the purposes of this section, CMS will consider to be the payment amount for the payment amount benchmark quarter. If a published payment limit is not available for the applicable payment amount benchmark quarter, at 427.302(d)(1)(i), we proposed to calculate the payment amount in the payment amount benchmark quarter using positive ASP or positive WAC data reported by manufacturers to the ASP Data Collection System

Specifically, we are finalizing a modification to the text of paragraph (l)(3)(iii) to remove the term equal such that the finalized regulation text at 425.610(l)(3)(iii) will read as follows, The performance payment limit or loss recoupment limit is set to the lesser of the amount calculated under paragraph (l)(2)(ii) of this section or the alternative amount calculated under paragraph (l)(3)(ii) of this section. (2) Exclude ACOs That Fall Below 5,000 Assigned Beneficiaries in any BY From Policies Providing Certain Low Revenue ACOs Participating in the BASIC Track Increased Opportunities To Share in Savings (a) Background With the CY 2023 PFS final rule (87 FR 69946 through 69952), we finalized an approach, under our authority of section 1899(i)(3) of the Act, [411] to expand the eligibility criteria to qualify for shared savings payments to enable certain low revenue ACOs participating in the BASIC track to share in savings even if the ACO does not meet the MSR as required under section 1899(d)(1)(B)(i) of the Act

BPC-157 is studied for cellular repair signalling, is associated with angiogenesis and growth factor pathways, and is frequently researched in gastrointestinal models
Some of these dogs also showed clinical signs suggestive of enteropathy, such as diarrhea and a failure to gain weight
Lv, X.-C., Guo, W.-L., Li, L., Yu, X.-D